VNDA

Vanda Pharmaceuticals Inc. News Headlines

$14.46
*  
0.36
2.55%
Get VNDA Alerts
*Delayed - data as of Jul. 9, 2014  -  Find a broker to begin trading VNDA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pipeline Update on Aratana - Analyst Blog
12/27/2013 5:45:01 PM - Zacks.com

Pipeline Update on Santarus Candidate - Analyst Blog
12/26/2013 6:10:01 PM - Zacks.com

Update on ARIAD's Iclusig - Analyst Blog
12/26/2013 5:45:01 PM - Zacks.com

Pipeline Progress at Athersys - Analyst Blog
12/24/2013 6:17:44 PM - Zacks.com

Update on AstraZeneca's Nexium Competition - Analyst Blog
12/24/2013 6:10:01 PM - Zacks.com

Update on Glaxo's HIV Drugs - Analyst Blog
12/24/2013 5:17:27 PM - Zacks.com

TESARO Plunges on Study Results - Analyst Blog
12/24/2013 12:17:42 PM - Zacks.com

Synthetic Biologics (SYN) in Focus: Stock Surges 18.1% - Tale of the Tape
12/24/2013 10:18:10 AM - Zacks.com

Update on Sanofi/REGN's Alirocumab - Analyst Blog
12/23/2013 6:18:13 PM - Zacks.com

Affymetrix Reaches New 52-Week High - Analyst Blog
12/23/2013 4:00:01 PM - Zacks.com

Update on Eylea - Analyst Blog
12/23/2013 3:18:51 PM - Zacks.com

Update on Endo's Acquisition Strategy - Analyst Blog
12/23/2013 1:10:01 PM - Zacks.com

Jazz Pharma to Acquire Gentium - Analyst Blog
12/20/2013 11:17:37 AM - Zacks.com

Positive Data on Gilead's Sovaldi - Analyst Blog
12/19/2013 6:17:29 PM - Zacks.com

Merck-Glaxo Partner for Oncology Treatment - Analyst Blog
12/19/2013 2:17:59 PM - Zacks.com

Orphan Drug Designation for Omeros' OMS721 - Analyst Blog
12/19/2013 12:17:32 PM - Zacks.com

Gilead's Sovaldi Holds Promise - Analyst Blog
12/18/2013 5:17:52 PM - Zacks.com

Priority Review for GSK, Genmab's Arzerra - Analyst Blog
12/18/2013 12:50:01 PM - Zacks.com

MYGN Announces Results of HRD Test - Analyst Blog
12/17/2013 7:33:14 PM - Zacks.com

Glaxo Increases Stake in Indian Subsidiary - Analyst Blog
12/17/2013 5:32:46 PM - Zacks.com

Agenus (AGEN) Soars: Stock Adds 12.7% in Session - Tale of the Tape
12/17/2013 9:33:57 AM - Zacks.com

IART Publishes Positive Study Results - Analyst Blog
12/16/2013 8:10:01 PM - Zacks.com

Update on Alexion's Voluntary Recall - Analyst Blog
12/16/2013 12:33:27 PM - Zacks.com

Label of Gilead's Complera Expanded - Analyst Blog
12/16/2013 12:33:20 PM - Zacks.com

Update on Endo's AMS Unit - Analyst Blog
12/16/2013 12:30:01 PM - Zacks.com